April 24, 2017
How many do we need?
This morning we learned of yet another closed loop insulin delivery system, i.e. artificial pancreas under development. Per a post on the Drug Delivery web site;
“Cellnovo (EPA:CLNV) and Diabeloop said this week they are launching a CE Mark cross-over registration study for an artificial pancreas device Diabeloop is developing which uses Cellnovo’s insulin pump . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.
